Published on 9 Mar 2023 on Zacks via Yahoo Finance

Does Immuneering Corporation (IMRX) Have the Potential to Rally 210.19% as Wall Street Analysts...

Shares of Immuneering Corporation (IMRX) have gained 72.3% over the past four weeks to close the last trading session at $6.77, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $21 indicates a potential upside of 210.2%.

The average comprises five short-term price targets ranging from a low of $5 to a high of $41, with a standard deviation of $13.29. While the lowest estimate indicates a decline of 26.1% from the current price level, the most optimistic estimate points to a 505.6% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.